(Q41250355)

28 September 2017

1 reference

title

Advanced glycation end-products and atherosclerosis (English)

1 reference

28 September 2017

1 reference

Vlassara H

1

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 October 1996

1 reference

28 September 2017

1 reference

28 September 2017

volume

28

1 reference

28 September 2017

issue

5

1 reference

28 September 2017

page(s)

419-426

1 reference

The Maillard reaction in vivo

28 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Chemistry of collagen cross-links: glucose-mediated covalent cross-linking of type-IV collagen in lens capsules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Production and characterization of antibodies to advanced glycation products on proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Retardation by Aminoguanidine of Development of Albuminuria, Mesangial Expansion, and Tissue Fluorescence in Streptozocin-Induced Diabetic Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Aminoguanidine effects on nerve blood flow, vascular permeability, electrophysiology, and oxygen free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Effects of aminoguanidine on peripheral nerve function and polyol pathway metabolites in streptozotocin-diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

High-affinity-receptor-mediated uptake and degradation of glucose-modified proteins: a potential mechanism for the removal of senescent macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Oligosaccharyltransferase activity is associated with a protein complex composed of ribophorins I and II and a 48 kd protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Isolation of cDNAs encoding a substrate for protein kinase C: nucleotide sequence and chromosomal mapping of the gene for a human 80K protein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation-modified proteins to a conserved motif.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Advanced glycosylation end products in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899608999102

10.3109/07853899608999102

21 January 2018

Identifiers

DOI

1 reference

release_g577jiehozdk7fxonzwbr2qvi4

28 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g577jiehozdk7fxonzwbr2qvi4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference